MORTALITY AND ITS RISK FACTORS AMONG IN-PATIENTS WITH INVASIVE ASPERGILLOSIS TREATED WITH VORICONAZOLE. SEATROPH [Internet]. 2022 Mar. 10 [cited 2026 Apr. 16];53(2):142-50. Available from: https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/551